https://doi.org/10.4081/hmr.v2i7.402

Combined modality treatment for early-stage Hodgkin’s lymphoma: the GHSG experience

Vol. 2 No. 7: New Insights in Hematology, Venice (Italy), May 14-17, 2006
Published: June 8, 2009
Abstract Views: 171
PDF: 1031
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

S Sasse
support@pagepress.org
V Diehl
A Engert
The prognosis of patients has substantially improved over the last decades. Currently, approximately 80% of all patients remain disease free 5 years after treatment.1 On the basis of clinical staging and risk factors as listed in Table 1 patients with Hodgkin lymphoma (HL) are usually classified into early favourable stages (CS 1-2 without risk factors), early-unfavorable stages (CS I-II with risk factors) or advanced stages. Here, we report on the experience of the GHSG and others in the treatment of early favourable and unfavourable HL.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Sasse, S., Diehl, V., & Engert, A. (2009). Combined modality treatment for early-stage Hodgkin’s lymphoma: the GHSG experience. Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.402
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).